StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the stock.
China Pharma Price Performance
China Pharma stock opened at $0.23 on Thursday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a twelve month low of $0.13 and a twelve month high of $0.44. The company’s 50-day moving average price is $0.22 and its two-hundred day moving average price is $0.21.
China Pharma Company Profile
Read More
- Five stocks we like better than China Pharma
- When to Sell a Stock for Profit or Loss
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- With Risk Tolerance, One Size Does Not Fit All
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Insider Trades May Not Tell You What You Think
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
